优化微流体配方和有机助剂,以改善脂质纳米粒子介导的基因组编辑
Rohan Palanki1,2, Emily L Han1, Amanda M Murray1
1Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, 19104, USA. mjmitch@seas.upenn.edu.
Lab on a chip
|July 22, 2024
概括
优化可电离性脂质纳米颗粒 (LNP) 增强了用于基因编辑的mRNA传递. 这项研究开发了一种新的LNP配方,用于有效地将CRISPR-Cas9传递给肝细胞,为遗传疾病提供了有前途的新疗法.
科学领域:
- 生物技术和基因工程 生物技术和基因工程
- 纳米医学和药物输送系统
背景情况:
- 基于mRNA的基因编辑对遗传疾病具有显著的治疗潜力.
- 为了实现这一潜力,有效和安全的in vivo核酸货物的运输至关重要.
- 电离性脂质纳米颗粒 (LNP) 是先进的非病毒RNA输送系统,但需要针对基于mRNA的CRISPR-Cas9平台进行优化.
研究的目的:
- 研究微流体和脂质辅助剂参数对LNP基因编辑疗效的影响.
- 发现优化的LNP配方,以增强基于mRNA的CRISPR-Cas9系统的交付.
主要方法:
- 对LNP配方,不同的脂,胆固醇和脂质-PEG结构进行系统选.
- 在体外评估肝细胞中的基因编辑效率.
- 在体内评估使用优化LNP配方的治疗性蛋白质减少.
主要成果:
- 根据脂质辅助剂的组成,确定了LNP递送功效的明显趋势.
- 一种结合高性能辅助剂的新型LNP配方证明了in vitro基因编辑的3倍增加.
- 与未经优化的配方相比,优化的LNP配方在体内减少了目标蛋白的3倍.
结论:
- 对LNP配方参数的系统优化对于增强基因编辑交付至关重要.
- 一种新的LNP配方显示了针对性地将基因编辑器输送到肝脏的巨大潜力.
- 这种优化的LNP平台可以成为治疗代谢和其他遗传疾病的宝贵工具.
相关概念视频
00:49What is Genetic Engineering?
Overview
01:22Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
01:28Methods of Medium Optimization
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...